Advance Patient Choice Archives - Dialysis Patient Citizens

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.
Gallery

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Hannah Bracamonte2024-10-24T12:55:43+00:00October 21st, 2024|Categories: Article, Immunosuppressive Drug Coverage, Medicare Advantage, News, Promote Financial Security|

By Susan Jaffe October 21, 2024 When Pam McClure learned she’d save nearly $4,000 on her prescription drugs next year, she said, “it sounded too good to be true.” She and her husband are both retired and live on a “very strict” budget in central North Dakota. By the end of this year, she will have spent almost $6,000 for her medications, including a drug to control her diabetes. McClure, 70, is one of about 3.2 million people with Medicare prescription drug insurance whose out-of-pocket medication costs will be capped at $2,000 in 2025 because of the Biden administration’s 2022 Inflation Reduction Act, according [...]

Private Insurance for Dialysis Care Introduced in the Senate
Gallery

Private Insurance for Dialysis Care Introduced in the Senate

Hannah Bracamonte2024-09-26T14:10:02+00:00September 25th, 2024|Categories: Advance Patient Choice, Article, Improve Access to Care, Private Insurance Coverage, Promote Financial Security, Protect Patient Care|

Senators Bill Cassidy (R-LA), Cory Booker (D-NJ) and Martin Heinrich (D-NM) recently introduced The Restore Protections for Dialysis Patients Act (S. 5018), which is the Senate companion to H.R. 6860 introduced earlier this year. If you are a dialysis patient, you may be eligible for Medicare, but you also have the right to keep your private employer-sponsored health insurance for up to 30 months after being diagnosed with kidney failure. However, a recent U.S. Supreme Court decision could limit your access to private coverage by allowing health plans to cut dialysis benefits from their networks and impose stricter rules. Along [...]

First class of Community Health Workers complete Chronic Kidney Disease training program
Gallery

First class of Community Health Workers complete Chronic Kidney Disease training program

Hannah Bracamonte2024-09-26T14:10:05+00:00September 2nd, 2024|Categories: Advance Patient Choice, Article, Improve Access to Care, Increase Quality of Care, Promote Financial Security|

DPC is pleased to announce that the first graduating class of community health workers (CHW) from Illinois have completed the Chronic Kidney Disease CHW training curriculum. DPC has led this effort in Illinois over the last two years, developing the first-in-the-nation kidney disease training curriculum for CHWs. The training will help CHWs educate their communities about kidney disease and help people at risk for kidney failure learn how to take care of their health, slow disease progression and reduce the number of people who start dialysis in the hospital emergency room as they are not aware that their kidneys are [...]

State Advocacy Update – Council of State Governments Meetings
Gallery

State Advocacy Update – Council of State Governments Meetings

Hannah Bracamonte2024-07-25T17:45:31+00:00July 25th, 2024|Categories: Advance Patient Choice, Article, Improve Access to Care, Increase Quality of Care, Medigap Coverage, News, Policy Issues, Promote Financial Security, Protect Patient Care, State Advocacy|

DPC’s two State Advocacy Directors have been busy advocating for dialysis patients this summer. Pamela Zielske, DPC’s Western Region Advocacy Director, attended the 77th Council of State Governments Annual Meeting in Portland, Oregon earlier this month. The event provided an outstanding opportunity to cultivate relationships with state legislators and attend policy sessions and legislative learning labs, including one hosted by Fresenius Medical Care on Improving Equity and Health Outcomes in Kidney Health Care. With legislators in attendance from 13 western states, the CSG West Meeting was a tremendous opportunity to elevate our advocacy work on behalf of dialysis patients with [...]

Dialysis Patient Citizens Announces First-in-the-Nation Kidney Disease Training Curriculum for Community Health Workers
Gallery

Dialysis Patient Citizens Announces First-in-the-Nation Kidney Disease Training Curriculum for Community Health Workers

Hannah Bracamonte2024-07-11T16:38:32+00:00July 11th, 2024|Categories: Advance Patient Choice, Improve Access to Care, Increase Quality of Care, Press Release|

Registration is now open for community health workers to sign up for the CHW Chronic Kidney Disease Training through the Illinois Public Health Association WASHINGTON, D.C. (July 11, 2024) - Today, Dialysis Patient Citizens (DPC), the nation’s largest non-profit advocacy organization for dialysis patients and their families, is announcing a first-in-the-nation kidney disease training curriculum for community health workers. The training will help community health workers educate their communities about kidney disease and help people at risk for kidney failure learn how to take care of their health and slow the progression of the disease. “Community health workers are an [...]

DPC Asks Medicare Officials to Reverse Pruritis Drug Fiasco
Gallery

DPC Asks Medicare Officials to Reverse Pruritis Drug Fiasco

Hannah Bracamonte2024-06-27T14:45:47+00:00June 12th, 2024|Categories: Advance Patient Choice, Article, Increase Quality of Care, Innovation, Protect Patient Care, Treatment Options|

In a letter to the Center for Medicare and Medicaid Services (CMS), Dialysis Patient Citizens (DPC) asked for a “do-over” in the rollout of Korsuva, a drug that treats ESRD-related pruritis. Medicare makes an add-on payment for new drugs that expires after two years, leaving uncertainty about how providers can offer such drugs to patients when that period ends. This uncertainty discouraged nephrologists from prescribing the medication. Empirical research has found a prevalence of moderate to severe pruritis among dialysis patients of 33 percent, but Korsuva has been dispensed to fewer than one percent of patients. In the letter, several DPC [...]

DPC’s Letter to Hon. Jonathan Blum, Principal Deputy Administrator for CMS, on New Drugs in the ESRD PPS
Gallery

DPC’s Letter to Hon. Jonathan Blum, Principal Deputy Administrator for CMS, on New Drugs in the ESRD PPS

Hannah Bracamonte2024-06-27T14:42:14+00:00June 11th, 2024|Categories: Advance Patient Choice, Comment Letter, Increase Quality of Care, Innovation, Protect Patient Care, Treatment Options|

June 11, 2024 The Honorable Jonathan Blum Principal Deputy Administrator Centers for Medicare & Medicaid Services 200 Independence Avenue, SW Washington, DC 20515 Re: New drugs in the ESRD PPS Dear Principal Deputy Administrator Blum: In our comments on the 2024 ESRD payment rule, we expressed our concerns about how patients experienced the rollout of Korsuva, the drug that treats ESRD-related pruritis. We noted that the prescribing behavior of nephrologists has amounted to, in effect, a de facto embargo of the medication. Empirical research has found a prevalence of moderate to severe pruritis among dialysis patients of 33 percent, but [...]

DPC’s 2024 Advocacy Day
Gallery

DPC’s 2024 Advocacy Day

Hannah Bracamonte2024-05-23T14:34:34+00:00May 20th, 2024|Categories: Advance Patient Choice, Article, Get Involved, Improve Access to Care, Increase Quality of Care, Medigap Coverage, News, Patient Ambassadors, Private Insurance Coverage, Promote Financial Security, Protect Patient Care|

Earlier this month, DPC hosted our annual Advocacy Day in Washington, D.C. where we bring together patients, family members, and care givers to meet with their Members of Congress to elevate the patient story for dialysis patients. This year we had 65 advocates attend, representing 25 states, who had almost 80 Congressional meetings. Our patients spoke to Congressional offices asking them to support H.R. 6860 – The Restore Protections for Dialysis Patients Act and H.R. 5027 – The Chronic Kidney Disease Improvement in Research and Treatment Act. These two bills would allow dialysis patients access to private insurance and Medigap [...]

DPC Seeks Information on Patients’ Experience With Itching
Gallery

DPC Seeks Information on Patients’ Experience With Itching

Hannah Bracamonte2024-04-24T16:12:21+00:00April 24th, 2024|Categories: Advance Patient Choice, Article, Increase Quality of Care, Innovation, Medicare Advantage, Treatment Options|

A couple of years ago, a new drug was approved to treat ESRD-related pruritis. Medicare approved an additional payment for the drug Korsuva for a period of 2 years. But, because of the short expiration date, very few nephrologists prescribed the medication, so even fewer dialysis facilities dispensed the drug. As a result, Korsuva never took hold to become the standard of care for pruritis. We’d like to know (1) Have experienced pruritis? (2) If so, did your clinicians tell you about Korsuva? We would like to convey patients’ experiences as we ask for Medicare to revisit coverage: what it’s like [...]

DPC Celebrates 20th Anniversary
Gallery

DPC Celebrates 20th Anniversary

Hannah Bracamonte2024-04-24T16:16:22+00:00April 1st, 2024|Categories: About DPC, Advance Patient Choice, Article, Get Involved, Improve Access to Care, Increase Quality of Care, Patient Ambassadors, Promote Financial Security, Protect Patient Care|

Since our founding 20 years ago, Dialysis Patient Citizens (DPC) has had the privilege of working with amazing advocates to help elevate the patient voice with policy makers to improve their quality of life. At our upcoming Advocacy Day Conference, May 5 – 7, 2024, we are excited to: honor the incredible work of our patient advocates; thank key Congressional Champions; and recognize some of our kidney community allies. Advocates from across the country will also take their stories to Capitol Hill to advocate for additional patient protections. To all of our patient advocates, family members, care partners, and kidney community [...]

Dialysis Patient Citizens

Recent News